http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103421056-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056 |
filingDate | 2012-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103421056-B |
titleOfInvention | Glucosamine-modified 3-dioxane derivatives, Its Preparation Method And Use |
abstract | The present invention relates to glucosamine-modified 3-dioxane derivatives, Its Preparation Method And Use.Specifically, the present invention relates to glucosamine-modified 3-dioxane derivatives or its pharmacy acceptable salt, the wherein R of general formula (I)n 1 be selected from H, benzyl, benzoyl or Cn 1-10 alkyloyl, Rn 2 be selected from H, Cn 1-10 alkyl, Cn 1-10 alkoxyl group, Cn 6-14 aryl or Cn 5-14 heterocyclic radical, wherein said alkyl is optionally by Cn 6-14 aryl or Cn 5-14 heteroaryl replaces.The invention still further relates to the preparation method of general formula (I) compound, the pharmaceutical composition containing general formula (I) compound and above-claimed cpd are preparing the purposes in anti-inflammatory drug. |
priorityDate | 2012-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.